http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 08 Jan 2026 05:00:00 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Saluda+Medical+Receives+Regulatory+Approval+for+EVA%E2%84%A2+Sensing+Technology+in+Europe+with+recognition+in+Australia/25822250.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.mn.minnea" idsrc="xmltag.org" >MINNEAPOLIS</location></span>, <span class="legendSpanClass"><chron>Jan. 8, 2026</chron></span> /PRNewswire/ -- <span value="Australia:SLD" idsrc="xmltag.org" >Saluda Medical, Inc.</span> (ASX:SLD, "Saluda" or the "Company"), a commercial-stage medical device company focused on developing treatments for chronic neurological conditions using its novel closed-loop neuromodulation platform, announced that, as expected, its next-generation EVA™ Sensing Technology has now received CE certification for <span>commercialization </span>in <location value="LR/eur" idsrc="xmltag.org" >Europe</location> with recognition of this approval in <location value="LC/au" idsrc="xmltag.org" >Australia</location>. This follows FDA approval of EVA in <chron>December 2024</chron>.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/Saluda+Medical+Receives+Regulatory+Approval+for+EVA%E2%84%A2+Sensing+Technology+in+Europe+with+recognition+in+Australia/25822250.html Thu, 08 Jan 2026 05:00:00 -0500 SLD http://www.streetinsider.com/PRNewswire/Saluda+Medical+Receives+Regulatory+Approval+for+EVA%E2%84%A2+Sensing+Technology+in+Europe+with+recognition+in+Australia/25822250.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.mn.minnea" idsrc="xmltag.org" >MINNEAPOLIS</location></span>, <span class="legendSpanClass"><chron>Jan. 8, 2026</chron></span> /PRNewswire/ -- <span value="Australia:SLD" idsrc="xmltag.org" >Saluda Medical, Inc.</span> (ASX:SLD, "Saluda" or the "Company"), a commercial-stage medical device company focused on developing treatments for chronic neurological conditions using its novel closed-loop neuromodulation platform, announced that, as expected, its next-generation EVA™ Sensing Technology has now received CE certification for <span>commercialization </span>in <location value="LR/eur" idsrc="xmltag.org" >Europe</location> with recognition of this approval in <location value="LC/au" idsrc="xmltag.org" >Australia</location>. This follows FDA approval of EVA in <chron>December 2024</chron>.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/PRNewswire/Saluda+Medical+Receives+Regulatory+Approval+for+EVA%E2%84%A2+Sensing+Technology+in+Europe+with+recognition+in+Australia/25822250.html Thu, 08 Jan 2026 05:00:00 -0500 SLD http://www.streetinsider.com/Press+Releases/Saluda+Medical+Raises+%24150M+USD+to+Fuel+Growth+Following+ASX+IPO/25714735.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.mn.minnea" idsrc="xmltag.org" >MINNEAPOLIS</location></span>, <span class="legendSpanClass"><chron>Dec. 9, 2025</chron></span> /PRNewswire/ -- <span value="Australia:SLD" idsrc="xmltag.org" >Saluda Medical, Inc.</span> (ASX:SLD, "Saluda" or the "Company"), a commercial-stage medical device company focused on developing treatments for chronic neurological conditions using its novel closed-loop neuromodulation platform, announced it has commenced trading on the <span value="ACORN:1747569917" idsrc="xmltag.org">Australian Securities Exchange</span> (ASX) following the completion of its initial public offering (IPO).</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Saluda+Medical+Raises+%24150M+USD+to+Fuel+Growth+Following+ASX+IPO/25714735.html Tue, 09 Dec 2025 07:00:00 -0500 A.12626223 A.17475699 A.35146065 A.50214029 O.00181231 O.00729847 O.00812673 O.55113340 SLD http://www.streetinsider.com/Press+Releases/Saluda+Medical+Raises+%24150M+USD+to+Fuel+Growth+Following+ASX+IPO/25714735.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.mn.minnea" idsrc="xmltag.org" >MINNEAPOLIS</location></span>, <span class="legendSpanClass"><chron>Dec. 9, 2025</chron></span> /PRNewswire/ -- <span value="Australia:SLD" idsrc="xmltag.org" >Saluda Medical, Inc.</span> (ASX:SLD, "Saluda" or the "Company"), a commercial-stage medical device company focused on developing treatments for chronic neurological conditions using its novel closed-loop neuromodulation platform, announced it has commenced trading on the <span value="ACORN:1747569917" idsrc="xmltag.org">Australian Securities Exchange</span> (ASX) following the completion of its initial public offering (IPO).</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Saluda+Medical+Raises+%24150M+USD+to+Fuel+Growth+Following+ASX+IPO/25714735.html Tue, 09 Dec 2025 07:00:00 -0500 A.12626223 A.17475699 A.35146065 A.50214029 O.00181231 O.00729847 O.00812673 O.55113340 SLD http://www.streetinsider.com/Press+Releases/Saluda+Medical+Raises+%24150M+USD+to+Fuel+Growth+Following+ASX+IPO/25714735.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.mn.minnea" idsrc="xmltag.org" >MINNEAPOLIS</location></span>, <span class="legendSpanClass"><chron>Dec. 9, 2025</chron></span> /PRNewswire/ -- <span value="Australia:SLD" idsrc="xmltag.org" >Saluda Medical, Inc.</span> (ASX:SLD, "Saluda" or the "Company"), a commercial-stage medical device company focused on developing treatments for chronic neurological conditions using its novel closed-loop neuromodulation platform, announced it has commenced trading on the <span value="ACORN:1747569917" idsrc="xmltag.org">Australian Securities Exchange</span> (ASX) following the completion of its initial public offering (IPO).</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Saluda+Medical+Raises+%24150M+USD+to+Fuel+Growth+Following+ASX+IPO/25714735.html Tue, 09 Dec 2025 07:00:00 -0500 A.12626223 A.17475699 A.35146065 A.50214029 O.00181231 O.00729847 O.00812673 O.55113340 SLD http://www.streetinsider.com/Press+Releases/Saluda+Medical+Raises+%24150M+USD+to+Fuel+Growth+Following+ASX+IPO/25714735.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.mn.minnea" idsrc="xmltag.org" >MINNEAPOLIS</location></span>, <span class="legendSpanClass"><chron>Dec. 9, 2025</chron></span> /PRNewswire/ -- <span value="Australia:SLD" idsrc="xmltag.org" >Saluda Medical, Inc.</span> (ASX:SLD, "Saluda" or the "Company"), a commercial-stage medical device company focused on developing treatments for chronic neurological conditions using its novel closed-loop neuromodulation platform, announced it has commenced trading on the <span value="ACORN:1747569917" idsrc="xmltag.org">Australian Securities Exchange</span> (ASX) following the completion of its initial public offering (IPO).</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Saluda+Medical+Raises+%24150M+USD+to+Fuel+Growth+Following+ASX+IPO/25714735.html Tue, 09 Dec 2025 07:00:00 -0500 A.12626223 A.17475699 A.35146065 A.50214029 O.00181231 O.00729847 O.00812673 O.55113340 SLD http://www.streetinsider.com/Press+Releases/Saluda+Medical+Raises+%24150M+USD+to+Fuel+Growth+Following+ASX+IPO/25714735.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.mn.minnea" idsrc="xmltag.org" >MINNEAPOLIS</location></span>, <span class="legendSpanClass"><chron>Dec. 9, 2025</chron></span> /PRNewswire/ -- <span value="Australia:SLD" idsrc="xmltag.org" >Saluda Medical, Inc.</span> (ASX:SLD, "Saluda" or the "Company"), a commercial-stage medical device company focused on developing treatments for chronic neurological conditions using its novel closed-loop neuromodulation platform, announced it has commenced trading on the <span value="ACORN:1747569917" idsrc="xmltag.org">Australian Securities Exchange</span> (ASX) following the completion of its initial public offering (IPO).</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Saluda+Medical+Raises+%24150M+USD+to+Fuel+Growth+Following+ASX+IPO/25714735.html Tue, 09 Dec 2025 07:00:00 -0500 A.12626223 A.17475699 A.35146065 A.50214029 O.00181231 O.00729847 O.00812673 O.55113340 SLD http://www.streetinsider.com/Press+Releases/Saluda+Medical+Raises+%24150M+USD+to+Fuel+Growth+Following+ASX+IPO/25714735.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.mn.minnea" idsrc="xmltag.org" >MINNEAPOLIS</location></span>, <span class="legendSpanClass"><chron>Dec. 9, 2025</chron></span> /PRNewswire/ -- <span value="Australia:SLD" idsrc="xmltag.org" >Saluda Medical, Inc.</span> (ASX:SLD, "Saluda" or the "Company"), a commercial-stage medical device company focused on developing treatments for chronic neurological conditions using its novel closed-loop neuromodulation platform, announced it has commenced trading on the <span value="ACORN:1747569917" idsrc="xmltag.org">Australian Securities Exchange</span> (ASX) following the completion of its initial public offering (IPO).</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Saluda+Medical+Raises+%24150M+USD+to+Fuel+Growth+Following+ASX+IPO/25714735.html Tue, 09 Dec 2025 07:00:00 -0500 A.12626223 A.17475699 A.35146065 A.50214029 O.00181231 O.00729847 O.00812673 O.55113340 SLD http://www.streetinsider.com/Press+Releases/Saluda+Medical+Raises+%24150M+USD+to+Fuel+Growth+Following+ASX+IPO/25714735.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.mn.minnea" idsrc="xmltag.org" >MINNEAPOLIS</location></span>, <span class="legendSpanClass"><chron>Dec. 9, 2025</chron></span> /PRNewswire/ -- <span value="Australia:SLD" idsrc="xmltag.org" >Saluda Medical, Inc.</span> (ASX:SLD, "Saluda" or the "Company"), a commercial-stage medical device company focused on developing treatments for chronic neurological conditions using its novel closed-loop neuromodulation platform, announced it has commenced trading on the <span value="ACORN:1747569917" idsrc="xmltag.org">Australian Securities Exchange</span> (ASX) following the completion of its initial public offering (IPO).</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Saluda+Medical+Raises+%24150M+USD+to+Fuel+Growth+Following+ASX+IPO/25714735.html Tue, 09 Dec 2025 07:00:00 -0500 A.12626223 A.17475699 A.35146065 A.50214029 O.00181231 O.00729847 O.00812673 O.55113340 SLD http://www.streetinsider.com/Press+Releases/Saluda+Medical+Raises+%24150M+USD+to+Fuel+Growth+Following+ASX+IPO/25714735.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.mn.minnea" idsrc="xmltag.org" >MINNEAPOLIS</location></span>, <span class="legendSpanClass"><chron>Dec. 9, 2025</chron></span> /PRNewswire/ -- <span value="Australia:SLD" idsrc="xmltag.org" >Saluda Medical, Inc.</span> (ASX:SLD, "Saluda" or the "Company"), a commercial-stage medical device company focused on developing treatments for chronic neurological conditions using its novel closed-loop neuromodulation platform, announced it has commenced trading on the <span value="ACORN:1747569917" idsrc="xmltag.org">Australian Securities Exchange</span> (ASX) following the completion of its initial public offering (IPO).</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Saluda+Medical+Raises+%24150M+USD+to+Fuel+Growth+Following+ASX+IPO/25714735.html Tue, 09 Dec 2025 07:00:00 -0500 A.12626223 A.17475699 A.35146065 A.50214029 O.00181231 O.00729847 O.00812673 O.55113340 SLD http://www.streetinsider.com/Press+Releases/Saluda+Medical+Raises+%24150M+USD+to+Fuel+Growth+Following+ASX+IPO/25714735.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.mn.minnea" idsrc="xmltag.org" >MINNEAPOLIS</location></span>, <span class="legendSpanClass"><chron>Dec. 9, 2025</chron></span> /PRNewswire/ -- <span value="Australia:SLD" idsrc="xmltag.org" >Saluda Medical, Inc.</span> (ASX:SLD, "Saluda" or the "Company"), a commercial-stage medical device company focused on developing treatments for chronic neurological conditions using its novel closed-loop neuromodulation platform, announced it has commenced trading on the <span value="ACORN:1747569917" idsrc="xmltag.org">Australian Securities Exchange</span> (ASX) following the completion of its initial public offering (IPO).</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Saluda+Medical+Raises+%24150M+USD+to+Fuel+Growth+Following+ASX+IPO/25714735.html Tue, 09 Dec 2025 07:00:00 -0500 A.12626223 A.17475699 A.35146065 A.50214029 O.00181231 O.00729847 O.00812673 O.55113340 SLD http://www.streetinsider.com/PRNewswire/Saluda+Medical+Raises+%24150M+USD+to+Fuel+Growth+Following+ASX+IPO/25714735.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.mn.minnea" idsrc="xmltag.org" >MINNEAPOLIS</location></span>, <span class="legendSpanClass"><chron>Dec. 9, 2025</chron></span> /PRNewswire/ -- <span value="Australia:SLD" idsrc="xmltag.org" >Saluda Medical, Inc.</span> (ASX:SLD, "Saluda" or the "Company"), a commercial-stage medical device company focused on developing treatments for chronic neurological conditions using its novel closed-loop neuromodulation platform, announced it has commenced trading on the <span value="ACORN:1747569917" idsrc="xmltag.org">Australian Securities Exchange</span> (ASX) following the completion of its initial public offering (IPO).</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/PRNewswire/Saluda+Medical+Raises+%24150M+USD+to+Fuel+Growth+Following+ASX+IPO/25714735.html Tue, 09 Dec 2025 07:00:00 -0500 A.12626223 A.17475699 A.35146065 A.50214029 O.00181231 O.00729847 O.00812673 O.55113340 SLD http://www.streetinsider.com/PRNewswire/Saluda+Medical+Raises+%24150M+USD+to+Fuel+Growth+Following+ASX+IPO/25714735.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.mn.minnea" idsrc="xmltag.org" >MINNEAPOLIS</location></span>, <span class="legendSpanClass"><chron>Dec. 9, 2025</chron></span> /PRNewswire/ -- <span value="Australia:SLD" idsrc="xmltag.org" >Saluda Medical, Inc.</span> (ASX:SLD, "Saluda" or the "Company"), a commercial-stage medical device company focused on developing treatments for chronic neurological conditions using its novel closed-loop neuromodulation platform, announced it has commenced trading on the <span value="ACORN:1747569917" idsrc="xmltag.org">Australian Securities Exchange</span> (ASX) following the completion of its initial public offering (IPO).</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/PRNewswire/Saluda+Medical+Raises+%24150M+USD+to+Fuel+Growth+Following+ASX+IPO/25714735.html Tue, 09 Dec 2025 07:00:00 -0500 A.12626223 A.17475699 A.35146065 A.50214029 O.00181231 O.00729847 O.00812673 O.55113340 SLD http://www.streetinsider.com/PRNewswire/Saluda+Medical+Raises+%24150M+USD+to+Fuel+Growth+Following+ASX+IPO/25714735.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.mn.minnea" idsrc="xmltag.org" >MINNEAPOLIS</location></span>, <span class="legendSpanClass"><chron>Dec. 9, 2025</chron></span> /PRNewswire/ -- <span value="Australia:SLD" idsrc="xmltag.org" >Saluda Medical, Inc.</span> (ASX:SLD, "Saluda" or the "Company"), a commercial-stage medical device company focused on developing treatments for chronic neurological conditions using its novel closed-loop neuromodulation platform, announced it has commenced trading on the <span value="ACORN:1747569917" idsrc="xmltag.org">Australian Securities Exchange</span> (ASX) following the completion of its initial public offering (IPO).</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/PRNewswire/Saluda+Medical+Raises+%24150M+USD+to+Fuel+Growth+Following+ASX+IPO/25714735.html Tue, 09 Dec 2025 07:00:00 -0500 A.12626223 A.17475699 A.35146065 A.50214029 O.00181231 O.00729847 O.00812673 O.55113340 SLD http://www.streetinsider.com/PRNewswire/Saluda+Medical+Raises+%24150M+USD+to+Fuel+Growth+Following+ASX+IPO/25714735.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.mn.minnea" idsrc="xmltag.org" >MINNEAPOLIS</location></span>, <span class="legendSpanClass"><chron>Dec. 9, 2025</chron></span> /PRNewswire/ -- <span value="Australia:SLD" idsrc="xmltag.org" >Saluda Medical, Inc.</span> (ASX:SLD, "Saluda" or the "Company"), a commercial-stage medical device company focused on developing treatments for chronic neurological conditions using its novel closed-loop neuromodulation platform, announced it has commenced trading on the <span value="ACORN:1747569917" idsrc="xmltag.org">Australian Securities Exchange</span> (ASX) following the completion of its initial public offering (IPO).</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/PRNewswire/Saluda+Medical+Raises+%24150M+USD+to+Fuel+Growth+Following+ASX+IPO/25714735.html Tue, 09 Dec 2025 07:00:00 -0500 A.12626223 A.17475699 A.35146065 A.50214029 O.00181231 O.00729847 O.00812673 O.55113340 SLD http://www.streetinsider.com/PRNewswire/Saluda+Medical+Raises+%24150M+USD+to+Fuel+Growth+Following+ASX+IPO/25714735.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.mn.minnea" idsrc="xmltag.org" >MINNEAPOLIS</location></span>, <span class="legendSpanClass"><chron>Dec. 9, 2025</chron></span> /PRNewswire/ -- <span value="Australia:SLD" idsrc="xmltag.org" >Saluda Medical, Inc.</span> (ASX:SLD, "Saluda" or the "Company"), a commercial-stage medical device company focused on developing treatments for chronic neurological conditions using its novel closed-loop neuromodulation platform, announced it has commenced trading on the <span value="ACORN:1747569917" idsrc="xmltag.org">Australian Securities Exchange</span> (ASX) following the completion of its initial public offering (IPO).</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/PRNewswire/Saluda+Medical+Raises+%24150M+USD+to+Fuel+Growth+Following+ASX+IPO/25714735.html Tue, 09 Dec 2025 07:00:00 -0500 A.12626223 A.17475699 A.35146065 A.50214029 O.00181231 O.00729847 O.00812673 O.55113340 SLD http://www.streetinsider.com/PRNewswire/Saluda+Medical+Raises+%24150M+USD+to+Fuel+Growth+Following+ASX+IPO/25714735.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.mn.minnea" idsrc="xmltag.org" >MINNEAPOLIS</location></span>, <span class="legendSpanClass"><chron>Dec. 9, 2025</chron></span> /PRNewswire/ -- <span value="Australia:SLD" idsrc="xmltag.org" >Saluda Medical, Inc.</span> (ASX:SLD, "Saluda" or the "Company"), a commercial-stage medical device company focused on developing treatments for chronic neurological conditions using its novel closed-loop neuromodulation platform, announced it has commenced trading on the <span value="ACORN:1747569917" idsrc="xmltag.org">Australian Securities Exchange</span> (ASX) following the completion of its initial public offering (IPO).</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/PRNewswire/Saluda+Medical+Raises+%24150M+USD+to+Fuel+Growth+Following+ASX+IPO/25714735.html Tue, 09 Dec 2025 07:00:00 -0500 A.12626223 A.17475699 A.35146065 A.50214029 O.00181231 O.00729847 O.00812673 O.55113340 SLD http://www.streetinsider.com/PRNewswire/Saluda+Medical+Raises+%24150M+USD+to+Fuel+Growth+Following+ASX+IPO/25714735.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.mn.minnea" idsrc="xmltag.org" >MINNEAPOLIS</location></span>, <span class="legendSpanClass"><chron>Dec. 9, 2025</chron></span> /PRNewswire/ -- <span value="Australia:SLD" idsrc="xmltag.org" >Saluda Medical, Inc.</span> (ASX:SLD, "Saluda" or the "Company"), a commercial-stage medical device company focused on developing treatments for chronic neurological conditions using its novel closed-loop neuromodulation platform, announced it has commenced trading on the <span value="ACORN:1747569917" idsrc="xmltag.org">Australian Securities Exchange</span> (ASX) following the completion of its initial public offering (IPO).</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/PRNewswire/Saluda+Medical+Raises+%24150M+USD+to+Fuel+Growth+Following+ASX+IPO/25714735.html Tue, 09 Dec 2025 07:00:00 -0500 A.12626223 A.17475699 A.35146065 A.50214029 O.00181231 O.00729847 O.00812673 O.55113340 SLD http://www.streetinsider.com/PRNewswire/Saluda+Medical+Raises+%24150M+USD+to+Fuel+Growth+Following+ASX+IPO/25714735.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.mn.minnea" idsrc="xmltag.org" >MINNEAPOLIS</location></span>, <span class="legendSpanClass"><chron>Dec. 9, 2025</chron></span> /PRNewswire/ -- <span value="Australia:SLD" idsrc="xmltag.org" >Saluda Medical, Inc.</span> (ASX:SLD, "Saluda" or the "Company"), a commercial-stage medical device company focused on developing treatments for chronic neurological conditions using its novel closed-loop neuromodulation platform, announced it has commenced trading on the <span value="ACORN:1747569917" idsrc="xmltag.org">Australian Securities Exchange</span> (ASX) following the completion of its initial public offering (IPO).</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/PRNewswire/Saluda+Medical+Raises+%24150M+USD+to+Fuel+Growth+Following+ASX+IPO/25714735.html Tue, 09 Dec 2025 07:00:00 -0500 A.12626223 A.17475699 A.35146065 A.50214029 O.00181231 O.00729847 O.00812673 O.55113340 SLD http://www.streetinsider.com/PRNewswire/Saluda+Medical+Raises+%24150M+USD+to+Fuel+Growth+Following+ASX+IPO/25714735.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.mn.minnea" idsrc="xmltag.org" >MINNEAPOLIS</location></span>, <span class="legendSpanClass"><chron>Dec. 9, 2025</chron></span> /PRNewswire/ -- <span value="Australia:SLD" idsrc="xmltag.org" >Saluda Medical, Inc.</span> (ASX:SLD, "Saluda" or the "Company"), a commercial-stage medical device company focused on developing treatments for chronic neurological conditions using its novel closed-loop neuromodulation platform, announced it has commenced trading on the <span value="ACORN:1747569917" idsrc="xmltag.org">Australian Securities Exchange</span> (ASX) following the completion of its initial public offering (IPO).</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/PRNewswire/Saluda+Medical+Raises+%24150M+USD+to+Fuel+Growth+Following+ASX+IPO/25714735.html Tue, 09 Dec 2025 07:00:00 -0500 A.12626223 A.17475699 A.35146065 A.50214029 O.00181231 O.00729847 O.00812673 O.55113340 SLD http://www.streetinsider.com/Press+Releases/SEEK+Invests+in+JobKorea%2C+Korea%26apos%3Bs+Largest+Recruitment+Platform%2C+as+part+of+a+Strategic+Path+to+be+the+Best+Digital+Career+Platform+in+Asia/18844155.html si-local-file:///var/storage/newsbody/2021/0819/18844155.html http://www.streetinsider.com/Press+Releases/SEEK+Invests+in+JobKorea%2C+Korea%26apos%3Bs+Largest+Recruitment+Platform%2C+as+part+of+a+Strategic+Path+to+be+the+Best+Digital+Career+Platform+in+Asia/18844155.html Thu, 19 Aug 2021 20:00:00 -0500 A.17475699 A.27944207 SEK SKLTY SLD http://www.streetinsider.com/Press+Releases/SEEK+Invests+in+JobKorea%2C+Korea%26apos%3Bs+Largest+Recruitment+Platform%2C+as+part+of+a+Strategic+Path+to+be+the+Best+Digital+Career+Platform+in+Asia/18844155.html si-local-file:///var/storage/newsbody/2021/0819/18844155.html http://www.streetinsider.com/Press+Releases/SEEK+Invests+in+JobKorea%2C+Korea%26apos%3Bs+Largest+Recruitment+Platform%2C+as+part+of+a+Strategic+Path+to+be+the+Best+Digital+Career+Platform+in+Asia/18844155.html Thu, 19 Aug 2021 20:00:00 -0500 A.17475699 A.27944207 SEK SKLTY SLD http://www.streetinsider.com/Press+Releases/SEEK+Invests+in+JobKorea%2C+Korea%26apos%3Bs+Largest+Recruitment+Platform%2C+as+part+of+a+Strategic+Path+to+be+the+Best+Digital+Career+Platform+in+Asia/18844155.html si-local-file:///var/storage/newsbody/2021/0819/18844155.html http://www.streetinsider.com/Press+Releases/SEEK+Invests+in+JobKorea%2C+Korea%26apos%3Bs+Largest+Recruitment+Platform%2C+as+part+of+a+Strategic+Path+to+be+the+Best+Digital+Career+Platform+in+Asia/18844155.html Thu, 19 Aug 2021 20:00:00 -0500 A.17475699 A.27944207 SEK SKLTY SLD http://www.streetinsider.com/Press+Releases/SEEK+Invests+in+JobKorea%2C+Korea%26apos%3Bs+Largest+Recruitment+Platform%2C+as+part+of+a+Strategic+Path+to+be+the+Best+Digital+Career+Platform+in+Asia/18844155.html si-local-file:///var/storage/newsbody/2021/0819/18844155.html http://www.streetinsider.com/Press+Releases/SEEK+Invests+in+JobKorea%2C+Korea%26apos%3Bs+Largest+Recruitment+Platform%2C+as+part+of+a+Strategic+Path+to+be+the+Best+Digital+Career+Platform+in+Asia/18844155.html Thu, 19 Aug 2021 20:00:00 -0500 A.17475699 A.27944207 SEK SKLTY SLD http://www.streetinsider.com/Press+Releases/SEEK+Invests+in+JobKorea%2C+Korea%26apos%3Bs+Largest+Recruitment+Platform%2C+as+part+of+a+Strategic+Path+to+be+the+Best+Digital+Career+Platform+in+Asia/18844155.html si-local-file:///var/storage/newsbody/2021/0819/18844155.html http://www.streetinsider.com/Press+Releases/SEEK+Invests+in+JobKorea%2C+Korea%26apos%3Bs+Largest+Recruitment+Platform%2C+as+part+of+a+Strategic+Path+to+be+the+Best+Digital+Career+Platform+in+Asia/18844155.html Thu, 19 Aug 2021 20:00:00 -0500 A.17475699 A.27944207 SEK SKLTY SLD